Clinical Trials
5
Active:0
Completed:5
Trial Phases
2 Phases
Phase 3:2
Phase 4:3
Drug Approvals
2
SFDA:1
CIMA_AEMPS:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Phase 3
2 (40.0%)Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia
Phase 4
Completed
- Conditions
- Anemia
- Interventions
- Drug: TOT'HEMA
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 167
- Registration Number
- NCT04309669
- Locations
- 🇫🇷
Hopital Pitié Salpétrière - Médecine Interne et Immunologie Clinique, Paris, France
Contraceptive Efficacy, Tolerance and Acceptability of a Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 151
- Registration Number
- NCT03102450
- Locations
- 🇫🇷
Cabinet Gynecologie, Paris, France
🇫🇷Cabinet de Gynecologie, Écully, France
🇫🇷Cabinet Gynecologique, Strasbourg, France
Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis
Phase 3
Completed
- Conditions
- Vaginitis
- Interventions
- Drug: GYNODAKTARIN®Drug: POLYGYNAX®Drug: Placebo
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 661
- Registration Number
- NCT02515656
- Locations
- 🇨🇿
TURKOVA, Praha, Czechia
🇫🇷PERCEVAL, Lyon, France
🇷🇸MARICIC, Belgrade, Serbia
Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis
Phase 4
Completed
- Conditions
- Vaginitis
- Interventions
- Drug: Polygynax combinaison of polymyxin, Neomycin and Nystatin
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 169
- Registration Number
- NCT02444481
Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs
Phase 3
Completed
- Conditions
- Chronic Venous Disease of Lower Limbs
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-02-15
- Last Posted Date
- 2013-04-29
- Lead Sponsor
- Laboratoire Innotech International
- Target Recruit Count
- 378
- Registration Number
- NCT01532882
- Locations
- 🇫🇷
Dr Jean-Jérôme GUEX, Nice, France
News
No news found